Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VSTM
#2909
Verastem, Inc.
5.9
3
USD
+4.77%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+4.77%
Monthly Change
+5.70%
6 month change
-33.74%
Year Change
+23.80%
Previous Close
5.6
6
Open
5.7
5
Bid
Ask
Low
5.7
4
High
5.9
4
Volume
493
Markets
US Stock Market
Healthcare
VSTM
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
14.31 M
15.53 M
16.72 M
25.3 M
51.49 M
87.84 M
—
Valuation ratios
Enterprise value
301.35 M
363.9 M
35.94 M
173.6 M
219.62 M
549.96 M
1.54 B
Price to earnings ratio
-4.84
-5
-1.1
-2.11
-1.41
-2.56
-7.48
Price to sales ratio
3.69
174.15
0.03
70.51
18.46
17.31
225.66
Price to cash flow ratio
-9.75
-6.68
-0
-2.12
-1.76
-3.89
-11.33
Price to book ratio
2.83
4.08
0
3.19
-6.39
9.35
-18.85
Enterprise value to EBITDA ratio
-31.18
-6.95
-0.13
-1.42
-1.54
-2.87
-7.94
Profitability ratios
Return on assets %
-0.44
-0.66
-0.78
-0.58
-1.29
-0.85
-1.22
Return on equity %
-0.59
-0.81
-1.56
-1.52
4.52
-3.66
6.66
Return on invested capital %
-558.36
-3 623.48
-7 730.47
-5 137.05
-6 190.86
-2 914.79
-3 718.67
Gross margin %
99.1
100
100
0
100
97.74
389.83
Operating margin %
-55.76
-2 991.18
-2 809.59
-3 547.15
-1 149.56
-550.33
-227.45
EBITDA margin %
-10.79
-2 526.64
-2 796.26
—
-1 149.35
-533
—
Net margin %
-76.51
-3 468.1
-2 843.3
-3 365.45
-1 306.37
-677.59
-5 131.02
Liquidity ratios
Quick ratio
—
—
—
—
—
3.07
—
Current ratio
8.48
5.69
4.29
5.45
3.07
3.09
12.63
Inventory turnover
—
—
—
—
—
0.28
—
Asset turnover
0.59
0.02
0.03
0
0.08
0.18
0.16
Solvency ratios
Debt to assets ratio
0.02
0.03
0.28
0.28
0.42
0.31
1.7
Debt to equity ratio
0.03
0.04
0.57
0.72
-1.46
1.34
-3.92
Long term debt to total assets ratio
0
0
0.26
0.27
0.4
0.31
1.68
Long term debt to total equity ratio
0
0
0.52
0.7
-1.41
1.33
-3.86
Per share metrics
Operating cash flow per share
-2.62
-3.68
-3 945.57
-3.92
-2.93
-1.98
-2.08
EBIT per share
-3.86
-4.23
-4 519.63
-4.18
-3.22
-2.45
-2.56
EBITDA per share
-0.75
-3.57
-4 498.19
-4.22
-3.22
-2.38
-2.52
Total debt per share
0.27
0.22
1 660.07
1.88
1.18
1.11
4.57
Cash per share
11.54
6.9
5 446.83
6.22
2.49
2.96
9.23
Net current asset value per share
11.34
7.28
5 754.8
6.52
2.66
3.22
9.98
Tangible book value per share
9.02
6.02
2 936.64
2.6
-0.81
0.59
-0.18
Working capital per share
10.01
6
4 412.43
5.32
1.79
2.18
6.79
Book value per share
9.02
6.02
2 936.64
2.6
-0.81
0.83
0.5
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
News
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com
Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market
Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play (NASDAQ:VSTM)
Verastem stock initiated at Buy by BTIG with $19 price target
Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High?
Jefferies reiterates Verastem stock rating on launch progress
Verastem, Inc. (VSTM) Q4 2025 Earnings Call Transcript
Verastem (VSTM) Reports Q4 Loss, Beats Revenue Estimates
3 Best Stocks With 125%+ Upside Ahead, According to Top Analysts, 3/2/2026 - TipRanks.com
What Makes Verastem (VSTM) a New Buy Stock
Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results